Liz Hatton died at her home in Harrogate, North Yorkshire, at the age of just 17, less than a year after being diagnosed with ...

Kylie Cunningham got news no one ever wants to hear, she had cancer. She was diagnosed with Sarcoma Cell Cancer that had ...

A new study has shown that adding a drug called pembrolizumab to standard treatments can improve survival for people with certain sarcomas.

Researchers observed responses in patients with synovial sarcoma or myxoid/round cell liposarcoma treated with lete-cel.

Last November, Pyxis revealed it would continue to focus on PYX-201 as its lead asset, while pausing other early-stage ...

Pyxis Oncology (NASDAQ:PYXS) is down ~38% in after-hours trading Wednesday after posting preliminary phase 1 data on PYX-201, ...

PYX-201 achieved a confirmed 50% ORR by RECIST 1.1 including one Complete Response and 100% Disease Control Rate in six heavily pretreated ...

Three Fred Hutch Cancer Center researchers received a five-year, $3.8 million award from the National Cancer Institute to ...

Intensity Therapeutics (INTS) announced that Christian Meyer M.D., Ph.D., Assistant Professor of Oncology and lead medical oncologist for adult ...

Gastrointestinal stromal tumours (GISTs) are clinically heterogeneous, with varying degrees of aggressiveness. Here, the authors describe the genomic and transcriptomic landscape of 117 GISTs from ...

Efti + KEYTRUDA combo shows strong efficacy for NSCLC patients in Immutep's phase 1 study. Read why IMMP stock may see upside ...